tiprankstipranks
Inmune Bio Grants CEO Stock Options Under Incentive Plan
Company Announcements

Inmune Bio Grants CEO Stock Options Under Incentive Plan

Don't Miss our Black Friday Offers:

Inmune Bio (INMB) has issued an announcement.

INmune Bio Inc. has recently granted their CEO, Ramond J. Tesi, an option to buy 37,882 shares at $8.72 each as part of their 2021 Stock Incentive Plan. This option became effective immediately and is set to expire on June 9, 2034, demonstrating the company’s confidence in their leadership and providing an incentive for continued success.

For detailed information about INMB stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyINmune Bio announces enrollment of 208 patients in Phase 2 trial of early AD
TipRanks Auto-Generated NewsdeskInmune Bio Emerges as Biotech Innovator in 2023
TheFlyINmune Bio holds an investor and analyst webinar
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App